Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 141

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 141
---
 intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)
of the Exchange Act or any “non-Rule 10b5-1 trading arrangement” (as defined in Section 408(c) of Regulation S-K).

ITEM 6. EXHIBITS

EXHIBIT INDEX

    Exhibit No.
     
    Description
  
    1.1
     
    Engagement Agreement (incorporated by reference to
    Exhibit 1.1 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    1.2
     
    Amendment to Engagement Agreement (incorporated by
    reference to Exhibit 1.2 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    1.3
     
    Extension to Engagement Agreement (incorporated by
    reference to Exhibit 1.3 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    4.1
     
    Form of Warrant (incorporated by reference to Exhibit
    4.1 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    4.2
     
    Form of Placement Agent Warrant (incorporated by reference
    to Exhibit 4.2 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    4.3
     
    Form of Warrant (incorporated by reference to Exhibit
    4.1 of the Company’s Current Report on Form 8-K filed on February 6, 2025)
  
    4.4
     
    Form of Placement Agent Warrant (incorporated by reference
    to Exhibit 4.2 of the Company’s Current Report on Form 8-K filed on February 6, 2025)
  
    10.1
     
    Form of Securities Purchase Agreement (incorporated
    by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed on January 30, 2025)
  
    10.2
     
    Form of Securities Purchase Agreement (incorporated
    by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed on February